1. Introduction {#sec0005}
===============

Modern therapy of human immunodeficiency virus (HIV) infections and acquired immunodeficiency syndrome (AIDS) is called combined antiretroviral therapy (cART). As the name suggests, the therapy combines at least three drugs from which at least two are classified in different groups ([Table 1](#tbl0005){ref-type="table"} ) based on their mechanism of activity (M-o-A) \[[@bib0005]\].Table 1Groups of antiretroviral drugs based on the mechanism of activity.Table 1Name of the groupMechanism of activity (M-o-A)Some representatives of the drug group1.nucleoside-analog reverse transcriptase inhibitors (NRTIs)--analogues of nucleoside substratesdrugs targeting reverse transcriptase (RT) of HIV *via* active site needed for transcription of RNA into DNAabacavir, didanosine, emtricitabine, lamivudine, stavudine, zalcitabine, zidovudine, tenofovir2.non-nucleoside reverse transcriptase inhibitors (NNRTIs)drugs targeting RT *via* allosteric modifications of a selected group of enzymes (affecting HIV-1, and not affecting HIV-2)etravirine, delavirdine, efavirenz, nevirapine3.integrase inhibitors (IIs)drugs targeting integrase, the enzyme responsible for integration of viral DNA into host DNAraltegravir, elvitegravir4.protease inhibitors (PIs)the target is an enzyme responsible for virion maturationamprenavir, atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, tipranavir5.fusion inhibitors (FIs)inhibitors of six helix bundle of gp41, a subunit of protein responsible for fusion of HIV particles with host cellsenfuvirtide6.co-receptor antagonistsdrugs targeting interaction of HIV gp120 and chemokine receptors *via* allosteric modificationmaraviroc

Unfortunately, cART is associated with numerous and various adverse effects in patients, ranging from mild to life-threatening \[[@bib0010]\]. Furthermore, resistance to almost all groups of drugs could occur in both HIV-1 and HIV-2 \[[@bib0015]\]. Finally, the therapy is not available to everyone, reaching an estimated 46% of infected people \[[@bib0020]\]. Bearing all of that in mind, it is clear why a constant search for safe, efficient and cheap drugs with significant anti-HIV effects is required.

So far, numerous studies have been conducted in order to evaluate antiviral properties of mainly medicinal and aromatic herbs, but also plants not used in traditional medicine \[[@bib0025]\]. Different plant-based products and isolated compounds of natural origin exhibited antiviral effects against various viruses, including HIV \[[@bib0030]\]. Different classes of bioactive compounds from plants, including flavonoids, coumarins, polyphenols, tannins, terpenoids, essential oils, alkaloids, polysaccharides and proteins were tested and proven to be active against a wide range of viral species \[[@bib0035]\].

The use of medicinal plants has numerous advantages. It was determined that HIV patients who opt for herbal treatment along side the conventional one have lower mortality, longer life expectancy and better life quality than the patients using only conventional therapy \[[@bib0040],[@bib0045]\]. Plants also have the potential to reduce the harmful effects of drugs \[[@bib0050]\]. Furthermore, there are some reports of case studies of people using only plants as therapy for HIV, who managed to keep the viral load undetectable during or after applied phytotherapy \[[@bib0055],[@bib0060]\]. Although plants and compounds discovered so far cannot replace conventional drugs, these reports provide a starting point for further examination of activity of some plants and their possible aplication in adjunctive therapy.

However, there are not many published papers that comprehensively present the data related to antiretroviral effects of particular groups of plants. Therefore, in this paper, the results of conducted studies on antiviral properties of selected genera and species of Lamiaceae family are summarized. The focus is set specifically on anti-HIV properties with possible or confirmed M-o-A, but the activities against other viruses are also described, with the purpose of providing supplementary data on antiviral properties.

Relevant articles were searched for through the PubMed database and Google Scholar, by using a combination of Latin or English names of selected plants with words "antiviral", "antiretroviral", "anti-HIV", "HIV" and "antimicrobial". The content of discovered articles was evaluated to determine their suitability for our topic. Afterwards, the references of the selected articles were examined for additional relevant literature. Only articles in the English language, with full text available were included.

2. Lamiaceae family {#sec0010}
===================

Lamiaceae (Labiatae) plant family is the sixth largest plant family, with \>200 genera and \>7000 species. Plants belonging to this family are dispersed worldwide and considered as some of the least difficult plants to cultivate. Coupled with easiness of cultivation, their aromatic, spicy properties make them an important part of pharmaceutical, food and cosmetic industries \[[@bib0065]\]. Plants discussed in this paper are herbaceous, so the parts most frequently used are leaves and *herba,* upper parts of the segment of the plant, mostly collected in full blossom. They can be used as fresh or dried material (as it is the case in culinary and food industries), but also in dosage forms specially prepared for external and internal use. Traditional forms of application for medicinal purposes include *infusum* (commonly called tea- form obtained by pouring nearly boiling water over the plant material), syrup, tincture, gargle (mouthwash), drops and many others. Besides drinking and using as mouthwash, these forms can be applied by rubbing and inhaling as well \[[@bib0070], [@bib0075], [@bib0080]\]. Some of the mainly used Lamiaceae plants are presented in [Table 2](#tbl0010){ref-type="table"} . Beside their traditional use, many of them are also accepted in conventional medicine. For this reason, the World Health Organization suggests that plants such as some Lamiaceae family representatives, with a long history of use and confirmed therapeutic effects should be further evaluated for new activities and properties that could be useful in treatment and prevention of different diseases \[[@bib0085]\].Table 2Some of the Lamiaceae plants discussed in the paper and their use in traditional and conventional medicine.Table 2Latin nameCommon nameSome of traditional usesReferenceUse in conventional medicine, approved by relevant institutionsReference*Thymus vulgaris*garden thymeantiseptic, carminative, eupeptic\[[@bib0090]\]bronchoantispasmodic, expectorant, antibacterial\[[@bib0095],[@bib0100],[@bib0105]\]*Thymus serpyllum*wild thymeantiseptic, spasmolytic, carminative, expectorant, sedative\[[@bib0075]\]antimicrobial\[[@bib0095]\]*Mentha* × *piperita*pepperminteupeptic, cholagogue, carminative, spasmolytic\[[@bib0110]\]antispasmodic, carminative, cholagogue, secretolytic, eupeptic (internally), cooling agent for myalgia and headache (externally)\[[@bib0095],[@bib0115],[@bib0120]\]*Rosmarinus officinalis*rosemarycholagogue, eupeptic, irritant, food additive\[[@bib0080]\]eupeptic, antispasmodic (internally), in rheumatic diseases and circulatory problems (externally)\[[@bib0095],[@bib0125],[@bib0130]\]*Melissa officinalis*lemon balmmild sedative, cholagogue, carminative\[[@bib0135]\]sedative, hypnotic, carminative (internally), symptomatic treatment of herpes labialis (externally)\[[@bib0095],[@bib0120],[@bib0140]\]*Origanum vulgare*oreganoantiparasitic, antihelmintic, cholagogue, carminative, spasmolytic\[[@bib0145]\]--*Origanum majorana*marjoramantispasmodic (internally), relief of irritated skin around nostrils (externally)\[[@bib0150]\]*Ocimum basilicum*sweet basilspasmolytic, eupeptic, carminative\[[@bib0155]\]--*Prunella vulgaris*self-healantifebrile, immunoregulator, anti-inflamatory, treatment of breast disorders\[[@bib0160]\]--*Hyssopus officinalis*hyssopantiseptic, expectorant\[[@bib0165]\]--*Salvia officinalis*common sageantiseptic, astringent, gastroprotective, anti-inflammatory, spasmolytic\[[@bib0170]\]eupeptic, inhibition of excessive perspiration (internally), antibacterial, virustatic, astringent (externally)\[[@bib0095],[@bib0175]\]*Satureja hortensis*summer savoryantiseptic, eupeptic, spasmolytic\[[@bib0180]\]--*Satureja montana*winter savory--[^1]

Different plants belonging to this family are classified into two subfamilies based on the presence of rosmarinic acid (Nepetoideae) or iridoids (Lamioideae). However, both of the plant groups of plants have various levels of essential oil (EO), with higher percent usually found in Nepetoideae subfamily \[[@bib0185],[@bib0190]\]. Plants from this family are well known for their antibacterial, antifungal and antioxidant properties \[[@bib0195], [@bib0200], [@bib0205], [@bib0210]\] and are used for extraction and isolation of a wide range of bioactive compounds \[[@bib0215], [@bib0220], [@bib0225]\]. This review included ten genera of Lamiaceae family, which are, to the best of our knowledge, the most widely known representatives, with distribution all over the world and a well-established tradition of use.

3. Anti(retro)viral properties of Lamiaceae {#sec0015}
===========================================

Antiviral effects of Lamiaceae plants have mainly been proven *in vitro*, with some effects also having been confirmed in other types of experiments, such as indirect effects in healthy volunteers, or in patients. The main findings are displayed in [Table 3](#tbl0015){ref-type="table"} - activity against HIV and [Table 4](#tbl0020){ref-type="table"} - activity against other viruses. The activity against HIV in [Table 3](#tbl0015){ref-type="table"} refers to HIV-1, unless otherwise stated.Table 3Some representatives of Lamiaceae family with anti-HIV activity.Table 3Plant speciesType of extractEC (μg/ml)SIAdditional commentsReferences***Thymus*****sp.** *T. quinquecostatus*AE314•activity in co-cultures of cells•weak activity against RT\[[@bib0230]\] *T. serpyllum*AE314•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\] *T. vulgaris*AE624\[[@bib0230]\]ME\>500\<3.00\[[@bib0235]\] *T. daenensis* subspecies *daenensis*ME3005.26•ME of plant's root increased PBMC and reduced CD4 receptor density\[[@bib0235]\] *T. daenensis* subspecies *lancifolius*ME\>500\<3.16\[[@bib0235]\] *T. kotschyanus*ME\>500\<3.18\[[@bib0235]\] *T. carmanicus*ME\>500\<3.11\[[@bib0235]\]  ***Mentha*****sp.** *Mentha* × *piperita* var. *citrata*AE1616•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\] *Mentha* × *piperita* s.l.--"grapefruit mint"AE168•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\] *Mentha* *×* *piperita*AE624\[[@bib0230]\]AE----•activity in both *in vitro* and *ex vivo* cell lines, without noticed toxicity\[[@bib0240]\]EE1252\[[@bib0230]\] *M. spicata*AE318•activity in co-cultures of cells•weak activity against RT\[[@bib0230]\] *M. pulegium*AE622\[[@bib0230]\]EE1254 *M. suaveolens*AE2504\[[@bib0230]\]EE624\[[@bib0230]\] *M. haplocalyx*AE----•weak activity against HIV protease\[[@bib0245]\]ME----•weak activity against HIV protease\[[@bib0245]\]  ***Rosmarinus*****sp.** *R. officinalis*AE624\[[@bib0230]\]EE2502\[[@bib0230]\]EE----•extract was found to be relatively non toxic, but there was a lack of significant effect against HIV\[[@bib0250]\]EE----•extract was found to be toxic•also, commercially available mixture with rosemary, sage, thyme and oregano was also toxic\[[@bib0255]\]  ***Melissa*****sp**. *M. officinalis*AE164•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\]AE----•activity in both *in vitro* and *ex vivo cell* lines, without noticed toxicity•activity against both enfuvirtide susceptible and resistant strains\[[@bib0240]\]  ***Origanum*****sp.** *O. majorana*AE318•activity in co-cultures of cells•weak activity against RT\[[@bib0230]\] *O. vulgare*AE318•activity in co-cultures of cells•weak activity against RT\[[@bib0230]\]  ***Ocimum*****sp.** *O. basilicum*AE314•activity in co-cultures of cells•weak activity against RT\[[@bib0230]\]EE125\>8\[[@bib0230]\] *O. basilicum* cultivar "cinnamon"AE168•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\]EE1000\>1\[[@bib0230]\] *O. gratissimum*AE10110•activity in co-cultures of cells•activity against RT and proviral DNA copying•activity against HIV-2 (EC = 75 μg/ml, SI = 14.7)\[[@bib0260]\]  ***Prunella*****sp.** *P. vulgaris*AE----•several researches demonstrated inhibition of HIV replication, without exhibited toxicity•concentrations displaying activity varied in wide range, approx. 1--68 μg/ml\[[@bib0230],[@bib0265], [@bib0270], [@bib0275], [@bib0280], [@bib0285]\]AE----•activity in co-cultures of cells\[[@bib0230],[@bib0270],[@bib0275],[@bib0285]\]AE----•inhibition of interaction between HIV gp120 and target CD4 receptor\[[@bib0270],[@bib0290]\]AE----•activity against RT\[[@bib0230],[@bib0290]\]AE----•dose-dependent activity against RT in non-competitive manner\[[@bib0275]\]AE----•potent activity against HIV protease\[[@bib0245]\]AE----•moderate activity against HIV integrase\[[@bib0295]\]AE----•potent activity against gp41 six-helix bundle formation\[[@bib0300]\]EE•less potent than AE\[[@bib0280]\]EE----•CXCR4 and CCR5 chemokine co-receptors were down-regulated both *in vitro* and *in vivo* in healthy volunteers\[[@bib0285]\]ME----•weak activity against HIV protease\[[@bib0245]\]EAE----•lack of activity\[[@bib0275]\]  ***Hyssopus*****sp.** *H. officinalis*AE----•several dilutions of crude extract displayed good to high activity, without noticed toxicity•several sub-fractions also displayed anti-HIV activity\[[@bib0305]\]EE----•extract was found to be relatively non toxic, but there was a lack of significant effect against HIV\[[@bib0250]\]  ***Salvia*****sp.** *S. officinalis*AE624•activity against HIV-1, both *in vitro* and *ex vivo*\[[@bib0230]\]AE----•activity in both *in vitro* and *ex vivo* cell lines, without noticed toxicity\[[@bib0240]\] *S. elegans*AE312•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\]EE312\[[@bib0230]\] *S. sclarea*AE2502\[[@bib0230]\] *S. miltiorrhiza*AE----•inhibition of interaction between HIV gp120 and target CD4 receptor•weak activity against RT\[[@bib0290]\]EE----•CCR5 chemokine co-receptors were down-regulated\[[@bib0285]\] *S. triloba*EE----•extract was found to be extremely toxic\[[@bib0250]\]  ***Satureja*****sp.** *S. hortensis*AE621\[[@bib0230]\] *S. montana*AE164•activity in co-cultures of cells•potent activity against RT\[[@bib0230]\][^2][^3][^4][^5][^6][^7][^8][^9][^10]Table 4Some representatives of Lamiaceae family with antiviral activities against other viruses.Table 4Plant speciesType of extract (with main compound(s))Additional commentsReferences**DNA Viruses With Envelopes** herpes simplex virus (HSV)  thymeEO (*p*-cymen and thymol)•activity against HSV-1•thyme species was not precisely determined\[[@bib0310]\]  *Thymus vulgaris*EO (thymol and carvacrol)•activity against HSV-1•activity against both acyclovir resistant and susceptible strains\[[@bib0315]\]EO (thymol and *p*-cymen)•activity against HSV-2\[[@bib0320]\]AE•activity against HSV-2\[[@bib0325]\]  *Thymus capitata*AE (derivate of apigenin), EE (thymol) and EO (thymol)•activity against bovine herpes virus (BHV-1), virus sometimes used as model for herpes virus\[[@bib0330]\]  *Thymus linearis*ME•activity against HSV-1\[[@bib0335]\]  *Mentha* *×* *piperita*EO (menthol and menthon)•activity against HSV-1 and HSV-2•activity against both acyclovir resistant and susceptible strains\[[@bib0340]\]  *Mentha suaveolens*EO (piperitenon oxide)•activity against HSV-1•synergistic effect with acyclovir\[[@bib0345]\]  *Rosmarinus officinalis*AE•activity against HSV-2\[[@bib0320]\]  *Melissa officinalis*EO (β-cubebene and β-caryophyllene)•activity against HSV-2\[[@bib0350]\]EO (geranial, β-caryophyllen and neral)•activity against HSV-1 and HSV-2\[[@bib0355]\]AE, EE•activity against HSV-1•no activity in rabbits (eye infection)\[[@bib0360]\]AE•activity against HSV-1\[[@bib0365]\]AE•activity against HSV-1•activity against both acyclovir resistant and susceptible strains\[[@bib0370]\]EE•activity against HSV-2\[[@bib0375]\]cream containing extract•efficient in patients with recurrent herpes simplex labialis•type of extract was not specified\[[@bib0380]\]  *Ocimum basilicum*AE, EE•activity against HSV-1 and HSV-2•AE was more potent than EE\[[@bib0385]\]  *Hyssopus officinalis*EO (isopinocamphone and 1-pinocamphone)•activity against HSV-1•activity against both acyclovir resistant and susceptible strains\[[@bib0390]\]EO (isopinocamphone and 1-pinocamphone)•activity against HSV-2\[[@bib0320]\]  *Salvia officinalis*AE, EE•activity against HSV-1 and HSV-2•EE was more potent than AE\[[@bib0355]\]AE•no activity against HSV-2\[[@bib0320]\]EO (1,8-cineol and α-thujone)•activity against HSV-1\[[@bib0395]\]creams containing extract•efficient in patients with recurrent herpes simplex labialis•sage, as well as sage and rhubarb mixture were both efficient\[[@bib0400]\]  *Satureja boliviana*AE, EE•activity against HSV-1•EE was found to be toxic\[[@bib0405]\]  *Satureja thymbra*EO (*p*-cymene, α-pinene and thymol)•activity against HSV-1\[[@bib0395]\]   hepatitis B virus  *Ocimum basilicum*AE, EE•AE was more potent than EE\[[@bib0385]\]  **RNA Viruses With Envelopes** influenza virus  *Thymus linearis*ME•no activity against human H1N1\[[@bib0335]\]  *Melissa officinalis*EO (geranial and neral)•activity against avian H9N2•synergistic effect with oseltamivir\[[@bib0410]\]EE•activity against human H1N1\[[@bib0415]\]  *Ocimum sanctum*ME•no activity against H1N1 *in ovo*\[[@bib0420]\]  *Prunella vulgaris*AE•activity against H1N1\[[@bib0425]\]   mumps, measles, vesicular stomatitis virus (VSV)  *Thymus vulgaris*AE•activity against all viruses\[[@bib0320]\]  *Rosmarinus officinalis*AE•activity against all viruses\[[@bib0320]\]  *Salvia officinalis*AE•activity against all viruses\[[@bib0320]\]  *Satureja boliviana*AE,EE•activity against VSV•EE was found to be toxic\[[@bib0405]\]   Newcastle Disease virus*  Thymus vulgaris*EE•activity *in ovo*\[[@bib0430]\]   SARS coronavirus  *Salvia officinalis*EO (1,8-cineol and α-thujone)\[[@bib0395]\]  *Satureja thymbra*EO (*p*-cymene, α-pinene and thymol)•no activity\[[@bib0395]\]   bovine viral diarrhoea virus  *Ocimum basilicum*EO•virus sometimes used as a surrogate model for hepatitis C virus\[[@bib0435]\]   yellow fever virus  *Origanum vulgare*EO (trans sabinene)\[[@bib0440]\]   dengue virus  *Ocimum sanctum*ME•no activity against serotype 1•high toxicity for cells\[[@bib0445]\]   ebola virus  *Prunella vulgaris*AE\[[@bib0450]\]   equine infectious anemia virus  *Prunella vulgaris*AE, EE•AE was more potent than EE\[[@bib0455]\]   Japanese encephalitis virus, Sindbis  *Salvia miltiorrhiza*AE, EAE•no activity against these viruses\[[@bib0460]\]  **DNA Viruses Without Envelopes** adenovirus  *Thymus mastichina*EO•no activity against human adenovirus serotype 2 (HAdV-2)\[[@bib0465]\]  *Ocimum basilicum*AE, EE•activity against ADV-3, ADV-8, ADV-11\[[@bib0385]\]  *Hyssopus officinalis*EO•no activity against human adenovirus serotype 2 (HAdV-2)\[[@bib0465]\]  **RNA Viruses Without Envelopes** echovirus 9  *Salvia miltiorrhiza*AE, EAE•no activity against these viruses\[[@bib0460]\]   polio virus  *Satureja boliviana*AE•no activity against poliovirus type 1\[[@bib0405]\]   norovirus  *Thymus mastichina*EO•no activity against murine norovirus MNV-1\[[@bib0465]\]  *Origanum vulgare*EO•activity against murine norovirus\[[@bib0470]\]  *Hyssopus officinalis*EO•no activity against murine norovirus MNV-1\[[@bib0465]\]   coxsackie virus  *Mentha haplocalyx*AE•activity against coxsackie virus A16•inhibition of inflammatory response of cell culture during viral replication\[[@bib0470]\]  *Ocimum basilicum*AE, EE•activity against coxsackie virus B1•AE was more potent than EE\[[@bib0385]\]  *Salvia miltiorrhiza*AE, EAE•no activity against coxsackie virus A16\[[@bib0460]\]   enterovirus  *Mentha haplocalyx*AE•no activity against enterovirus 71\[[@bib0470]\]  *Ocimum basilicum*AE, EE•activity against enterovirus 71•AE and EE were equally active\[[@bib0385]\]  *Salvia miltiorrhiza*AE, EAE•activity against three genotypes of enterovirus 71\[[@bib0460]\][^11][^12][^13][^14]

4. Natural products and considerations of adequate form {#sec0020}
=======================================================

An investigated substance (IS) can be:1.a plant extract obtained by using different solvents *e.g.* aqueous (AE), ethanolic (EE), methanolic (ME), ethyl acetate (ЕАE), *etc*.,2.an EO isolated from raw plant material mainly by hydro- or stem distillation and3.a single chemical compound, either of natural origin or (semi)synthesized.

The majority of tested plants were prepared in the form of AE. This type of extraction is probably the simplest for preparation, as it resembles the preparation of previously mentioned *infusum* (tea) which is used traditionally and convenient for use at patient's home \[[@bib0475]\]. Two other frequent types of extracts are EE and EO. The first type, EE can also be prepared at home (*e.g.* by macerating fresh or dried plants with diluted ethanol); and while ethanol can enhance the extraction of active compounds, higher concentrations of ethanol can show interactions with antiretroviral and other drugs. On the other hand, EOs are available as commercial products, and can be bought at different stores. Of course, only adequate application of EOs in patients (*e.g.* diluted in a lipid carrier) will prevent possible direct toxicity and allergic reactions \[[@bib0480]\]. Other types of extracts, obtained by using different solvents (*e.g.* chloroform, hexane...) have not been used for assessment of anti(retro)viral properties, probably due to their toxicity.

It is interesting to notice that conducted researches drew a comparison between several extracts. Yamasaki et al. \[[@bib0230]\] compared AE and EE for several plants, generally proving AE as more active against HIV. Other research generally supports this claim. In the case of self-heal, AE was also found to be superior in comparison to EE \[[@bib0280]\], while EAE exhibited no effects \[[@bib0275]\]. The latter paper also provided proof that AE can be absorbed from the intestine into blood, further giving potential for *in vivo* activity \[[@bib0275]\]. All of these data suggest that AEs are the most interesting types of extracts, which should be further studied for potential application in patients.

5. Active compounds in plants {#sec0025}
=============================

Usually, the first step in investigating of complex natural products' biological activity (including antiviral) is to determine the most abundant compound in any type of extract. Several of revised papers had this approach, and detection of some compounds led to further investigation of their activity against viruses.

5.1. Compounds with anti-HIV activity {#sec0030}
-------------------------------------

Out of all of the compounds found in rosemary, only carnosol ([Fig. 1](#fig0005){ref-type="fig"} ) exhibited inhibition of HIV replication with acceptable toxicity \[[@bib0255]\]. A chemical analysis of hyssop AE indicated a high concentration of caffeic acid ([Fig. 1](#fig0005){ref-type="fig"}) whose anti-HIV activity was later confirmed \[[@bib0305]\] and further investigation led to discovery of substituted polysaccharide, named MAR-10, another substance from hyssop with notable *in vitro* anti-HIV activity \[[@bib0485]\]. This is not the only polysaccharide with detected anti-HIV properties. Investigating inflorescence of self-heal, researchers were able to isolate sulfated polysaccharide named prunellin, with excellent activity against HIV, without detected cytotoxicity \[[@bib0270],[@bib0490]\]. Furthermore, various active compounds were isolated from different representatives of genus *Salvia* and tested for antiviral properties. Semi-synthesized caffeoyl-coumarin derivatives of sagecoumarin (isolated from *S. officinalis*) were proven to be extremely potent IIs, exhibiting activity in concentrations of 1--2 μmol l^−1^. Unfortunately, they exhibited poor activity against viral replication \[[@bib0495]\]. Lithospermic acid ([Fig. 1](#fig0005){ref-type="fig"}) and lithospermic acid B (polycyclic phenolic carboxylic acids) were isolated from *S. miltiorrhiza* (Danshen, red sage) root extract and were shown to be potent and selective IIs \[[@bib0500]\]. Molecular docking calculations predicted that these compounds would be effective even in the case of HIV strains resistant to conventional therapy \[[@bib0505]\]. Using root of *S. yunnanensis* (another biological source of Danshen), researchers isolated polyphenol salvianolic acid N, which exhibited notable anti-HIV-1 activity and RT and integrase inhibition *in vitro* \[[@bib0510]\]. Five more tested compounds: salvianolic acid A, methyl salvianolate A, ethyl salvianolate A, lithospermic acid and *cis*-lithospermic acid showed activity against HIV-1 replication in concentrations 2.04--6.11 μg ml^−1^. They were also good IIs, but weak inhibitors of RT and protease \[[@bib0515]\].Fig. 1Some compounds presumed to be responsible for anti(retro)viral effects.Fig. 1

5.2. Compounds with activity against other viruses {#sec0035}
--------------------------------------------------

Various compounds from Lamiaceae plants have been studied for their activity against DNA and RNA viruses, both with and without envelopes. A polysaccharide similar to prunellin demonstrated activity against HSV-1 (both acyclovir susceptible and resistant) and HSV-2. This activity appears to be specific against HSV, as this compound was found to be ineffective against DNA enveloped cytomegalovirus, RNA enveloped human influenza virus types A and B and VSV and against RNA non-enveloped poliovirus type 1 \[[@bib0520]\]. It was later demonstrated that another extracted polysaccharide acts against HSV antigen expression \[[@bib0525]\]. A third isolated polysaccharide, from the same plant, self-heal, also expressed anti-HSV activity, and its effectiveness was confirmed in skin and genital lesions in guinea pigs and mice, respectively \[[@bib0530]\]. Other types of compounds, diterpenes safficinolide and sageone, isolated from the common sage (*S. officinalis*) also exhibited anti-HSV-1 effects \[[@bib0535]\]. From the 2,5-dihydroxybenzoic acid (phenolic acid) and several glycosides of acacetin only weak activity against HSV-1 has been recorded \[[@bib0540]\]. Protocatehuic aldehide isolated from species *S. miltiorrhiza* expressed activity against duck HBV both *in vitro* (cell cultures) and *in vivo* (ducklings) \[[@bib0545]\].

Diterpene carnosic acid ([Fig. 1](#fig0005){ref-type="fig"}) was found to be effective against RNA enveloped respiratory syncytial virus (RSV) with acceptable toxicity \[[@bib0550]\]. Apigenin (flavonoid aglycone) and acacetin glycosides showed weak to moderate activity against human RSV Long strain \[[@bib0540]\]. The previously mentioned safficinolide and sageone exhibited effects against another RNA virus, VSV \[[@bib0535]\].

It is interesting to point out that the research even detected some compounds with activity against RNA non-enveloped viruses, generally viewed as more challenging for therapy. Rosmarinic acid ([Fig. 1](#fig0005){ref-type="fig"}) and lithospermate B, as single compounds from *S. miltiorrhiza,* were effective against enterovirus 71 \[[@bib0555]\]. Carvacrol ([Fig. 1](#fig0005){ref-type="fig"}) (commonly found as a major compound of *O. vulgare* EO) displayed activity against non-enveloped murine norovirus \[[@bib0560]\]. Ursolic acid ([Fig. 1](#fig0005){ref-type="fig"}) had excellent activity against RNA non-enveloped viruses such as coxackievirus B1 and enterovirus 71, but also against DNA non-enveloped adenoviruses \[[@bib0385]\]. *In silico* molecular studies of various compounds from *O. sanctum* also confirmed good antiviral activity of ursolic acid \[[@bib0565]\].

6. Activity *versus* toxicity {#sec0040}
=============================

The most important parameter that needs to be determined in antiviral testing is the minimum concentration needed for inhibition of viral replication. It is suggested that these values should be ≤100 μg mL^−1^ for extracts and EOs, and as it can be seen in [Table 3](#tbl0015){ref-type="table"}, majority of plants with activity against HIV follow this rule. However, this is not the only parameter that should be used for assessment of antiviral effectiveness of different plant based products. Due to the fact that studies of antiviral activity are performed in living systems (usually cell cultures), a minimum concentration that displays (cyto)toxicity should also be reported \[[@bib0570]\]. Selectivity index (SI) represents the ratio of determined cytotoxic concentration and effective concentration. SI is a valuable indicator of effectiveness of the tested substance, and, if the compound or mixture exhibits activity in low concentrations, it is not considered useful and applicable if its SI is also low. Only values of SI higher than 4 are considered appropriate \[[@bib0570],[@bib0575]\]. For example, carnosic acid was toxic for tested cells, even though it displayed potent activity against HIV integrase *in vitro* \[[@bib0580]\]. Compounds salvianolic acids D and E, isolated from different *Salvia* species, were proven to be extremely effective *in vitro* against HIV-1 integrase. However, they were not further evaluated for antiviral effects due to their toxicity \[[@bib0585]\]. Some plants' extracts *e.g.* EE of *Salvia triloba* \[[@bib0250]\], EE of *Satureja boliviana* \[[@bib0405]\], ME of *Ocimum sanctum* \[[@bib0445]\], commercially available rosemary extract and a mixture of Provençal Herbs (containing rosemary, sage, thyme and oregano) \[[@bib0255]\] were proven as toxic, so estimation of their anti(retro)viral activity was not possible.

7. Studying mechanism of antiviral activity {#sec0045}
===========================================

7.1. Time-of-addition (T-o-A) studies {#sec0050}
-------------------------------------

A notable number of studies reviewed in this paper have also tried to detect the exact M-o-A of IS. This was achieved through the time-of-addition (T-o-A) study, which is comprised of assays with different procedures of addition of IS, viral suspension and cell cultures \[[@bib0240],[@bib0270], [@bib0275], [@bib0280],[@bib0310], [@bib0315], [@bib0320],[@bib0330],[@bib0340],[@bib0345],[@bib0355],[@bib0365],[@bib0370],[@bib0385],[@bib0410],[@bib0435],[@bib0440],[@bib0455],[@bib0460],[@bib0470],[@bib0520],[@bib0530],[@bib0560]\]. Based on the highest activity in a certain assay, a conclusion about the exact type of M-o-A can be derived ([Fig. 2](#fig0010){ref-type="fig"} ). Generally, four assays for investigating antiviral effects of different mixtures and substances are in use:1.Pretreatment of the cell culture- IS is incubated with a cell culture, and after a certain time period, a viral suspension is added. In this case, the results show whether the IS was able to penetrate inside the cells and manifest its activity.2.Pretreatment of the virus- A viral suspension is incubated together with the IS. After the incubation, the suspension is rinsed of substance and inoculated into the cell culture. Activity in this assay indicates direct activity towards the virus and its structures, *e.g.* the envelope.3.Adsorption- The viral suspension and IS are added simultaneously into cell cultures. This assay indicates activity towards structures responsible for viral attachment and/or penetration of virus into the cells.4.Intracellular replication- IS is added during viral replication inside the cells. Substances showing activity in this assay are able to affect later stages of the viral life cycle \[[@bib0355]\]. Fig. 2Scheme of time-of-addition assays: A. pretreatment of cells (cells are treated with substance), B. pretreatment of virus (virus is treated with substance), C. adsorption (virus and substance are simultaneously added) and D. intracellular replication (substance is added during viral replication). Adapted and modified from Schnitzler et al. \[[@bib0355]\]. The figure was color-styled to be understandable by all readers, including colorblind, according to Roskoski \[[@bib0590]\].Fig. 2

In the case of different Lamiaceae species, the majority of IS, both extracts and single compounds, displayed activity in cases of pretreatment of viral particles. This resulted in strong and dose-dependent inhibition of viral infectivity. Several experiments suggested that viral envelope is the target site for ISs, as it is confirmed by comparing antiviral activities against enveloped and non-enveloped viral species. This is not a strict rule- some IS demonstrated activity against non-enveloped viruses \[[@bib0560]\] and there was no activity against some enveloped viruses \[[@bib0470]\].

Activity in cases of virus pretreatment does not exclude activity in the assay of adsorption inhibition; as it is possible that IS displays effects in a short period of time during simultaneous addition of IS and of viral particles into cell cultures. However, minor activity recorded in adsorption inhibition demonstrates that IS can affect both the viral envelope and other structures responsible for viral attachment and/or penetration into target cells.

Some research provided evidence that ISs had no lytic effects towards viral particles. These papers demonstrated that the integrity of particles was mantained after treatment with AEs of peppermint, lemon balm, common sage \[[@bib0240]\] and self-heal \[[@bib0280],[@bib0455]\] and EO of oregano and carvacrol \[[@bib0560]\].

Interestingly, a drastic change in HIV virion density after exposure to AEs of lemon balm and peppermint was detected \[[@bib0240]\]. Researchers presumed that this was the consequence of ISs interactions with macromolecules in viral structures, responsible for normal viral integrity and infectivity, although this was not confirmed with experiments. The change of density was not recorded in the case of HIV \[[@bib0280]\] or in the equine infectious anemia virus \[[@bib0455]\] treated with self-heal.

As it can be seen in [Table 4](#tbl0020){ref-type="table"}, EOs with different main compounds were also investigated for antiviral effects. Usually, only two or three compounds are present in higher concentrations and considered responsible for the activity. Main compounds in EO are usually determined by genetics, but different ecological factors could affect their concentration rather than the method used for isolation \[[@bib0595]\]. The effect of different main compounds in EO can be illustrated in the example of lemon balm. First EO with β-cubebene and β-caryophyllene as major compounds exhibited effects in cases of cell pretreatment with IS \[[@bib0350]\], while EO containing mainly geranial, β-caryophyllene and neral achieved effects when HSV-1 and HSV-2 viruses were pretreated and effects were absent in other T-o-A studies \[[@bib0355]\]. This leads to a conclusion that different compounds affect different stages of viral life cycle and achieve effect through different mechanisms.

7.2. Comparison with conventional drugs {#sec0055}
---------------------------------------

Researchers often compare natural products with conventional drugs, commonly included as positive control- this provides information on strength of activity of a natural product. Another possible reason for these assays is to determine whether IS has the same M-o-A.

In the case of HIV, there is frequent comparison of activity against RT ([Table 3](#tbl0015){ref-type="table"}). This unique and specific HIV enzyme is one of the key targets for conventional therapy, so it is no surprise that researchers tried to detect plants with activity against this enzyme. However, in HIV's life cycle, several other structures can also be targets, so natural products are also compared with drugs displaying other M-o-A. This can be ilustrated in the example of *Prunella vulgaris* (Xia Ku Cao, self-heal), a plant frequently used in Traditional Chinese Medicine. Besides activity against RT (which resembles the M-o-A of nucleoside RT inhibitors), AE demonstrated activity against enzymes integrase and protease, and inhibition of interaction of HIV gp120 and gp41 with corresponding structures on target cells, similar to activities of integrase inhibitors, protease inhibitors, co-receptor antagonists and fusion inhibitors, respectively ([Table 1](#tbl0005){ref-type="table"}, [Table 3](#tbl0015){ref-type="table"}), thus mimicking M-o-A of antiretroviral drugs. As it was previously mentioned, some isolated compounds were also found to have a M-o-A similar to conventional drugs.

8. Studying activity in cases of chronic HIV infection {#sec0060}
======================================================

Besides simulating acute infection, in the case of HIV it is also important to investigate the activity of compounds and natural products in chronic infection. This is achieved through simulation in an *in vitro* assay with non-infected cells and cells chronically infected with HIV (with cell lines being of the same or different origin). Techniques of these assays are versatile, but the general principle is to co-culture both cell cultures in the presence of IS, determining whether IS can prevent virus spreading to non-infected cells \[[@bib0600]\]. Some of the examined Lamiaceae species (lemon balm, self-heal, and some representatives from genera *Thymus*, *Mentha*, *Origanum*, *Ocimum*, *Salvia* and *Satureja*) exhibited this activity ([Table 3](#tbl0015){ref-type="table"}). However, the lack of effect may correspond with previously detected substance activity only in early stages of viral life cycle.

9. Potential position in the therapy {#sec0065}
====================================

Extracts and EOs can also be compared for their activity against different viral strains, both susceptible and resistant to conventional drugs. This was most frequently tested on herpes simplex viral strains, as resistance to acyclovir is a therapeutical problem. Several Lamiaceae representatives (thyme, peppermint, lemon balm, self-heal and hyssop) were tested simultaneously against acyclovir resistant and acyclovir susceptible strains of HSV. Interestingly, they were equally susceptible to used extracts \[[@bib0315],[@bib0340],[@bib0370]\]. Besides this, lemon balm was proven to be efficient in cases of HIV strains resistant to enfuviride, fusion inhibitor \[[@bib0240]\].

Potential synergism with conventional drugs could result in new recommendations of plant application with antiviral therapy. In revised literature, EO of *Mentha suaveolens* showed a synergistic effect with acyclovir against HSV-1 \[[@bib0345]\] and EO of lemon balm showed synergism with oseltamivir against avian H9N2 influenza virus \[[@bib0410]\]. In both cases, sub-optimal doses of drugs were enhanced with EOs, resulting in good antiviral activities.

Both of the previous cases (comparison of strains and synergism) have led to the conclusion that natural products can exhibit different M-o-A than conventional drugs. Still, idea of combining drugs (both conventional and herbal) with different M-o-A could be a good therapeutical approach. This is in accordance with the main idea of cART- use of several drugs results in good activity against virus, with decreased side effects and toxic properties of drugs.

10. The "non- *in vitro*" studies and future considerations {#sec0070}
===========================================================

As previously stated, the majority of studies are conducted *in vitro*. This is the main type of investigation due to convenience and lower cost of studies. However, concerning HIV, it is completely understandable from an ethical point of view why these *in vitro* studies are the only type of conducted studies, to the best of our knowledge. Still, some other types of investigations are being attempted, in order to get valid results, possibly applicable to patients.

Some papers investigated activity *in ovo* \[[@bib0420],[@bib0430]\]. This approach is presumably conducted in order to simulate natural living cells (rather than cell cultures), giving a more accurate answer to the question- Does IS show activity and lack of toxicity at the same time? Animal studies are not widely accepted, and only study by Dimitrova et al. \[[@bib0360]\] demonstrated a lack of activity of lemon balm against HSV-1 when it was tested in rabbits, in provoked eye infection.

Thyme and hyssop preparations were estimated for their ability to increase the number and/or viability of peripheral blood mononuclear cells (PBMCs) of healthy donors \[[@bib0235],[@bib0485]\]. A study by Feng et al. \[[@bib0285]\] included healthy volunteers who had taken self-heal for a week. These individuals had a reduced level of chemokine co-receptors in T cells, one of key structures in the HIV life cycle, and one of therapeutic targets. The positive outcome in these *ex vivo* and *in vivo* studies suggest modulatory effects of these plants towards immunity. This also suggest that antiviral activity can be indirect, rather than having direct effects (*e.g.* targeting viral envelope) as it is seen in *in vitro* studies.

Finally, some plants were studied for their activity in patients, in assays testing pharmaceutical formulations for local application in cases of recurrent herpes labialis. Commercially available cream containing extract of lemon balm was proven to be efficient in the treatment of this sometimes complex problem. The cream was able to reduce the intensity of complaints, number of blisters and affected area size in patients, especially if the application is started immediately after the onset of prodromes \[[@bib0380]\]. Also, creams containing sage extract, as well as sage and rhubarb mixture were proven to be efficient in the treatment of herpes labialis in patients. Application of these creams reduced the symptoms and duration of viral episodes \[[@bib0400]\]. These investigations of antiviral activity in some patients and their positive outcomes suggest that application of adequate formulations confirmed antiviral activity which was previously noted only *in vitro*. Local application is an effective type of treatment which may be advised to patients in addition to conventional therapy, reducing side effects of viral diseases.

As Lamiaceae plants are demonstrated to be effective *in vitro*, possible ideas for future researches would be to test these plants in patients with viral infections. The starting points would be to select a plant (possibly by using informations of effective concentrations and SIs) and adequate form (as it is previously explained, AE appears to be the most promising). Use of the most abundant compounds in products (some suggested in the previous text) is an even more precise approach to investigation. Application of plants should, however, be carefully monitored. Although the plants generally have many potential beneficial effects, they also have potential to cause interactions with antiretroviral and other drugs, resulting in a drastic increase or decrease of drug concentrations in patients, leading to toxicity or therapeutic failure. However, in cases of HIV, it is believed that prolonged exposure to drugs (not exceeding therapeutic concentrations) can be positive for patients, as it prevents selection of resistant strains and possibly decreases doses of conventional drugs, together with their side effects \[[@bib0605]\]. With careful monitoring of drug concentration, management of simultaneous use of conventional therapy and phytotherapy should not be a problem.

11. Conclusions {#sec0075}
===============

Numerous *in vitro* screenings pointed to notable anti(retro)viral properties of different species of the Lamiaceae family. The effect is generally strong and dose-dependent, and the most likely mechanism of activity is direct effect against outer structures (primarily viral envelop) consequentially disabling viral attachment to target cells. Several other experiments with local therapeutic forms gave encouraging results, demonstrating potential of Lamiaceae plants as adjunctive therapy. Further clinical trials could give final conclusions on antiviral activity and the application on patients.
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[^1]: \- Data not found in revised literature.

[^2]: \- Assay was not conducted/not applicable.

[^3]: EC- effective concentration, which displays activity against HIV.

[^4]: SI- selectivity index, ratio between toxic and effective concentration, parameter of (non) toxicity.

[^5]: AE- aqueous extract.

[^6]: EE- ethanolic extract.

[^7]: ME- methanolic extract.

[^8]: EAE- ethyl acetate extract.

[^9]: RT- reverse transcriptase.

[^10]: PBMC- peripheral blood mononuclear cells.

[^11]: EO- essential oil.

[^12]: AE- aqueous extract.

[^13]: EE- ethanolic extract.

[^14]: ME- methanolic extract.
